CoMind receives $100m+ funding for clinical brain monitoring
UK neurotechnology company CoMind has secured 102.5 million USD (~77m GBP) in funding to advance regulatory approval of the company’s first product, CoMind One. The company says this is the first device with the potential to non-invasively and continuously monitor
